Volinia, Stefano

Primary Appointment

Department of Molecular Virology, Immunology and Medical Genetics Human Cancer Genetics

Contact Information:

Office:

1096 Biomedical Research Tower
460 W 12th Avenue
Columbus, OH 43210
Ph. (614) 292-3670
stefano.volinia@osumc.edu  

Publications:

Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM.Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3024-9. Epub 2012 Feb 6. PMID: 22315424.

Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, Leblanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI. MicroRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 2012 Feb 20. PMID: 22350417.

Bomben R, Gobessi S, Bo MD, Volinia S, Marconi D, Tissino E, Benedetti D, Zucchetto A, Rossi D, Gaidano G, Poeta GD, Laurenti L, Efremov DG, Gattei V. The miR-17~92 family regulates the response to toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Leukemia. 2012 Feb 20. doi: 10.1038/leu.2012.44.

Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med. 2011 Dec 11;18(1):74-82. doi: 10.1038/nm.2577. PMID: 22157681.

Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, De Falco G, Githanga J, Horn H, Nyagol J, Ott G, Palatini J, Pfreundschuh M, Rogena E, Rosenwald A, Siebert R, Croce CM, Stein H. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia. 2011 Dec;25(12):1869-76. doi: 10.1038/leu.2011.156. Epub 2011 Jun 24. PubMed PMID: 21701491.

Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M, Volinia S, Taccioli C, Kipps TJ, Croce CM. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood. 2011 Sep 15;118(11):3072-9. Epub 2011 Jun 2. PubMed PMID: 21636858; PubMed Central PMCID: PMC3175784.

Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 2011 May 9;208(5):875-83. Epub 2011 Apr 25. PubMed PMID: 21518799; PubMed Central PMCID: PMC3092351.

Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, Croce CM. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4908-13. Epub 2011 Mar 7. PubMed PMID: 21383199; PubMed Central PMCID: PMC3064319.

Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, McGraw K, Clark JA, Sigua CA, Chen DT, Moscinski L, Croce CM, List AF. Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br J Haematol. 2011 Apr;153(1):24-32. doi: 10.1111/j.1365-2141.2011.08581.x. Epub 2011 Feb 21. PubMed PMID: 21332710.

Goparaju CM, Blasberg JD, Volinia S, Palatini J, Ivanov S, Donington JS, Croce C, Carbone M, Yang H, Pass HI. Onconase mediated NFKβ downregulation in malignant pleural mesothelioma. Oncogene. 2011 Jun 16;30(24):2767-77. doi: 10.1038/onc.2010.643. Epub 2011 Feb 14. PubMed PMID: 21317924; PubMed Central PMCID: PMC3118086.